Bryn S. Moore

1.4k total citations · 1 hit paper
15 papers, 994 citations indexed

About

Bryn S. Moore is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Bryn S. Moore has authored 15 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Genetics and 2 papers in Surgery. Recurrent topics in Bryn S. Moore's work include Genetic and Kidney Cyst Diseases (5 papers), Renal and related cancers (4 papers) and Hedgehog Signaling Pathway Studies (2 papers). Bryn S. Moore is often cited by papers focused on Genetic and Kidney Cyst Diseases (5 papers), Renal and related cancers (4 papers) and Hedgehog Signaling Pathway Studies (2 papers). Bryn S. Moore collaborates with scholars based in United States, United Kingdom and Netherlands. Bryn S. Moore's co-authors include Suresh S. Ramalingam, Erica Werner, Natalya Degtyareva, Giuseppe Altavilla, Rossella Marullo, Paul W. Doetsch, Tooraj Mirshahi, Alex R. Chang, Ann Stepanchick and William Triffo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Biological Chemistry.

In The Last Decade

Bryn S. Moore

15 papers receiving 985 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions

2013 617 citations Rossella Marullo, Erica Werner et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bryn S. Moore United States	11	557	231	171	162	104	15	994
Wen Zhou United States	16	299 0.5×	202 0.9×	69 0.4×	101 0.6×	58 0.6×	37	775
Ewa Marcinkowska Poland	24	746 1.3×	249 1.1×	483 2.8×	155 1.0×	89 0.9×	71	1.3k
Guido Orlandini Italy	19	539 1.0×	66 0.3×	287 1.7×	85 0.5×	47 0.5×	49	1.4k
Stephanie M. Stanford United States	23	907 1.6×	357 1.5×	50 0.3×	219 1.4×	68 0.7×	44	1.7k
Shanshan Cui China	19	506 0.9×	100 0.4×	66 0.4×	67 0.4×	205 2.0×	49	1.1k
Xuejian Zhao China	25	868 1.6×	150 0.6×	130 0.8×	408 2.5×	233 2.2×	62	1.7k
Toshiaki Fukushima Japan	24	842 1.5×	205 0.9×	88 0.5×	149 0.9×	124 1.2×	52	1.6k
Patricia García‐López Mexico	20	469 0.8×	48 0.2×	154 0.9×	191 1.2×	137 1.3×	54	1.1k
Delphine Courilleau France	15	788 1.4×	204 0.9×	61 0.4×	217 1.3×	97 0.9×	19	1.1k

Countries citing papers authored by Bryn S. Moore

Since Specialization

Citations

This map shows the geographic impact of Bryn S. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryn S. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryn S. Moore more than expected).

Fields of papers citing papers by Bryn S. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryn S. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryn S. Moore. The network helps show where Bryn S. Moore may publish in the future.

Co-authorship network of co-authors of Bryn S. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Bryn S. Moore. A scholar is included among the top collaborators of Bryn S. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryn S. Moore. Bryn S. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Solanki, Kaushal, Melissa Kelly, Karyn Meltz Steinberg, et al.. (2024). Genotype-First Analysis in an Unselected Health System–Based Population and Phenotypic Severity of COL4A5 Variants. Journal of the American Society of Nephrology. 36(6). 1138–1151. 2 indexed citations

Solanki, Kaushal, Yirui Hu, Bryn S. Moore, et al.. (2023). The Phenotypic Spectrum of COL4A3 Heterozygotes. Kidney International Reports. 8(10). 2088–2099. 18 indexed citations

Moore, Bryn S., Gurmukteshwar Singh, Prince Mohan, et al.. (2022). Individuals heterozygous for ALG8 protein-truncating variants are at increased risk of a mild cystic kidney disease. Kidney International. 103(3). 607–615. 17 indexed citations

Mirshahi, Uyenlinh L., Guoli Chen, Bryn S. Moore, et al.. (2022). Framework From a Multidisciplinary Approach for Transitioning Variants of Unknown Significance From Clinical Genetic Testing in Kidney Disease to a Definitive Classification. Kidney International Reports. 7(9). 2047–2058. 2 indexed citations

Chang, Alex R., Bryn S. Moore, Jonathan Z. Luo, et al.. (2022). Exome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney Disease. JAMA. 328(24). 2412–2412. 40 indexed citations

Moore, Bryn S., William Triffo, Natasha T. Strande, et al.. (2022). eP077: Atypical polycystic kidney disease in individuals heterozygous for rare ALG8 protein-truncating variants. Genetics in Medicine. 24(3). S50–S51. 1 indexed citations

Oetjens, Matthew T., Jonathan Z. Luo, Alex R. Chang, et al.. (2020). Electronic health record analysis identifies kidney disease as the leading risk factor for hospitalization in confirmed COVID-19 patients. PLoS ONE. 15(11). e0242182–e0242182. 27 indexed citations

Besse, Whitney, Alex R. Chang, Jonathan Z. Luo, et al.. (2019). ALG9 Mutation Carriers Develop Kidney and Liver Cysts. Journal of the American Society of Nephrology. 30(11). 2091–2102. 93 indexed citations

Moore, Bryn S. & Tooraj Mirshahi. (2018). Genetic variants help define the role of the MC4R C-terminus in signaling and cell surface stability. Scientific Reports. 8(1). 10397–10397. 10 indexed citations

10.

P, Pavan Kumar, et al.. (2016). T-box3 is a ciliary protein and regulates stability of the Gli3 transcription factor to control digit number. eLife. 5. 28 indexed citations

11.

Moore, Bryn S., Ann Stepanchick, Paul Tewson, et al.. (2016). Cilia have high cAMP levels that are inhibited by Sonic Hedgehog-regulated calcium dynamics. Proceedings of the National Academy of Sciences. 113(46). 13069–13074. 86 indexed citations

12.

Moore, Bryn S., Uyenlinh L. Mirshahi, Evan A. Yost, et al.. (2014). Long-Term Weight-Loss in Gastric Bypass Patients Carrying Melanocortin 4 Receptor Variants. PLoS ONE. 9(4). e93629–e93629. 34 indexed citations

13.

Marullo, Rossella, Erica Werner, Natalya Degtyareva, et al.. (2013). Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions. PLoS ONE. 8(11). e81162–e81162. 617 indexed citations breakdown →

14.

Moore, Bryn S., et al.. (2013). A Conserved Mechanism for Gating in an Ionotropic Glutamate Receptor. Journal of Biological Chemistry. 288(26). 18842–18852. 9 indexed citations

15.

Moore, Bryn S., et al.. (2011). Isolation, Characterization, and DNA Binding Kinetics of Three Dirhodium(II,II) Carboxyamidate Complexes: Rh₂(μ-L)(HNOCCF₃)₃ where L= [OOCCH₃]⁻, [OOCCF₃]⁻, or [HNOCCF₃]⁻. Inorganic Chemistry. 50(8). 3458–3463. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact